Research Article

Enhancement of Adiponectin Ameliorates Nonalcoholic Fatty Liver Disease via Inhibition of FoxO1 in Type I Diabetic Rats

Figure 2

Effects of the FoxO1 inhibitor (AS) and APN on serum AST, ALT, and TG. Serum AST, ALT, and TG were determined by kits (Stanbio Laboratory, TX, USA). Values are expressed as mean ± SD, . , .
(a)
(b)
(c)